Home
About
Pricing
Log In
Back
TRI
Asset Logo

Trivarx Ltd

🇦🇺 ASX

🩺 HEALTH CARE

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-5.19%
Annual Growth

5 years average annual capital growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

4
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

TrivarX Ltd. engages in clinical research, product development, and early-stage commercialization of mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is development of artificial intelligence (AI)-driven, scientifically based devices for screening and diagnosis of behavioral health conditions. Its clinical research has enabled the development of proprietary algorithms for spectral analyses of sleep architecture and heart-rate variability. The Company’s lead product, MEB-001 analyses the data from a standard sleep study to identify depression at a sensitivity of over 85%. Its technology analyses the electrical signals from the brain and the heart to identify mental illness.

📈 Performance

Price History

-97.44%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.01

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in TRI

4

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

26 weeks

💵 Average investment amount

$1,560

Last time a customer invested in TRI

401 days
TRI investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

14%

50k - 100k

43%

Less than 50k

29%
👶 Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
🙋 Legal gender of investors

Female

25%

Male

75%

Pearlers who invest in TRI also invest in...

Liontown Resources Limited

LTR

Liontown Resources Ltd. engages in the exploration and evaluation of minerals. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-12-27. The firm controls two major hard rock lithium deposits. The firm's projects include Kathleen Valley Project and Buldania Project. The Kathleen Valley Project is located in an established mining region about 60 kilometers north of Leinster and 680 kilometers north-east of Perth, Western Australia. The Kathleen Valley Lithium Project is a Tier-1 battery metals asset with excellent grade and scale in one of world's best mining districts. The Buldania Project is in the Eastern Goldfields Province of Western Australia, approximately 600 kilometers east of Perth. The Project is close to major road and rail infrastructure with direct access to the Port of Esperance 200 kilometers to the south. The firm's downstream expansion project includes investigating the potential for an integrated refinery to upgrade its spodumene from the Kathleen Valley mine to higher value lithium products.

🙌 Performance (5Yr p.a)

132.39%

📊 Share price

$0.84 AUD

⛏️ MINING

Find Out More

Qantas Airways Ltd. engages in international and domestic air transportation services. The company is headquartered in Mascot, New South Wales and currently employs 27,625 full-time employees. The principal activities of the Company include the operation of international and domestic air transportation services and provision of freight services and the operation of a frequent flyer loyalty program. The Company’s segments include Qantas Domestic, Qantas International, Jetstar Group, Qantas Loyalty, and Corporate. Qantas Domestic is a carrier in the Australian domestic market measured by capacity. Qantas Domestic offers on-board Wi-Fi and upgrades to the domestic lounges. Qantas International is a carrier into and out of Australia, also targeting business and premium leisure customers who value the full-service experience. Jetstar Group has domestic and international routes in Australia, joint ventures in Singapore and Japan. Qantas Loyalty is comprised of consumer and SME coalition loyalty programs. Its airline brands operate regional, domestic, and international services.

🙌 Performance (5Yr p.a)

46.71%

📊 Share price

$11.04 AUD

✈️ AIRLINES

🌳 ENVIRONMENTAL

🕊️ SOCIALLY AWARE

📈 HIGH PRICE GROWTH

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

🙌 Performance (5Yr p.a)

-0.59%

📊 Share price

$269.60 AUD

⚖️ HIGH GOVERNANCE

🕊️ SOCIALLY AWARE

🧬 BIOTECHNOLOGY

Deep Yellow Ltd. engages in the provision of acquisition, exploration, evaluation and development of uranium properties. The company is headquartered in Subiaco, Western Australia. Its projects include Namibian project portfolio comprises of Tumas Project, Omahola Projects, Nova joint venture (JV) Project, Yellow Dune JV Project, Mulga Rock Project, and Alligator River Project. The Tumas Project comprises of a series of palaeochannel/calcrete-type uranium deposits. Omahola Project is located within the prospective Alaskite Alley corridor, within which uranium deposits, including Rossing, Husab, Etango and Valencia are located. The Nova joint venture (JV) Project includes two exclusive prospecting licenses (EPL) prospective for both basement and palaeochannel-type uranium mineralization. The Yellow Dune JV comprises one mineral deposit retention license (MDRL) covering a drilled-out uranium resource of the palaeochannel/calcrete-type at Aussinanis. The Mulga Rock consists of two separate mining areas over a total length of 30 kilometers.

🙌 Performance (5Yr p.a)

110.00%

📊 Share price

$1.56 AUD

⚡️ ENERGY

The a2 Milk Co. Ltd. engages in the distribution and sale of milk and dairy products. The firm operates through four segments: Australia and New Zealand, China and Other Asia, USA and Mataura Valley Milk. The Australia and New Zealand segment includes the sale of infant formula, milk and other dairy products, along with royalty, license fees and rental income. The China and Other Asia segment includes the sale of infant formula, milk and other dairy products. The USA segment includes the sale of milk and license fees. The Mataura Valley Milk segment is engaged in manufacturing and sale of nutritional and commodity products. Its product portfolio is divided into three core categories: liquid milk, infant milk formula and macro milk. The company offers its products under a2 Milk and a2 Platinum brands. Its product includes a2 Milk Lite, a2 Milk Blue, a2 Platinum Premium toddler milk drink and others.

🙌 Performance (5Yr p.a)

-11.84%

📊 Share price

$7.87 AUD

🕊️ SOCIALLY AWARE

🍔 FOOD PRODUCTS

Want more shares? Try these...

📊 Share price

$0.03 AUD

NULL STOCK

Compare
Add to watchlist